The global platelet rich plasma market is expected to hit $400 million by 2023, growing at a 13.3 percent compound annual growth rate, according to a Qurate Business Intelligence report.
The rising geriatric population, which is more prone to orthopedic and neurological diseases, as well as an increasing incidence of sport injuries and orthopedic surgeries are contributing factors to the market growth.
Key players:
1. Zimmer Biomet
2. Stryker
3. DePuy Synthes
4. Isto Biologics
5. Exatech
6. Harvest Technologies
7. Arthrex
8. Regen Lab SA
9. Nuo Therapeutics